INDV Stock Summary and Trading Ideas (Indivior PLC - | NASDAQ:INDV)

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Indivior PLC - trades on the NASDAQ stock market under the symbol INDV.

As of January 9, 2026, INDV stock price declined to $35.44 with 2,355,101 million shares trading.

INDV has a beta of 0.63, meaning it tends to be less sensitive to market movements. INDV has a correlation of 0.04 to the broad based SPY ETF.

INDV has a market cap of $4.43 billion. This is considered a Mid Cap stock.

Last quarter Indivior PLC - reported $314 million in Revenue and $.72 earnings per share. This beat revenue expectation by $53 million and exceeded earnings estimates by $.32.

The top ETF exchange traded funds that INDV belongs to (by Net Assets): IJR, IWM, VXF, SPSM, IJT.

INDV has outperformed the market in the last year with a return of +193.1%, while the SPY ETF gained +19.0%. In the last 3 month period, INDV beat the market returning +46.7%, while SPY returned +3.7%. However, in the most recent 2 weeks INDV has underperformed the stock market by returning -2.1%, while SPY returned +0.5%.

INDV support price is $34.84 and resistance is $36.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INDV shares will trade within this expected range on the day.